Even if youre not on GLP-1 medications, this same pattern shows up in many people experiencing persistent bloating or abdominal distension
Journal of Clinical Oncology 40(2):202-212, 2022
To me, peptides represent perhaps the biggest challenge for anti-doping authorities today, and have also become a major consumer protection challenge
It was mainly observed in tissues such as the liver, kidney, and adipose tissue, and beneficial effects were observed within weeks of peptide administration in aged mice
The study found GLP-1 (7-36) to be more potent than GIP in stimulating the release of insulin
In this guide, well break down: What Cagrilintide is and how it was developed How it works to regulate appetite and metabolism Benefits seen in clinical research for weight loss and glycemic control Side effects and safety considerations Dosage and administration from ongoing studies How it compares to GLP-1s, stimulants, and other peptides Current legal status and future availability Cagrilintide is still in clinical trials, but the early data has positioned it as a potential next-generation therapy in the fight against obesity